FDA Inspection 1311392 — Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC
The FDA completed an inspection of Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC on Apr 8, 2026 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 8, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Andover, MA (United States)